Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

Detected CMS Systems:

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://journals.lww.com/immunotherapy-journal/abstract/2010/07000/dna_vaccine_encoding_prostatic_acid_phosphatase.9.aspx, but it redirected us to https://journals.lww.com/immunotherapy-journal/abstract/2010/07000/dna_vaccine_encoding_prostatic_acid_phosphatase.9.aspx. The analysis below is for the second page.

Title[redir]:
Journal of Immunotherapy
Description:
ave investigated plasmid DNA vaccines and have previously conducted a phase 1 trial in which patients with recurrent prostate cancer were vaccinated with a DNA vaccine encoding PAP. In this study, we investigated the immunologic efficacy of subsequent booster immunizations, and conducted more detailed longitudinal immune analysis, to answer several questions aimed at guiding optimal schedules of vaccine administration for future clinical trials. We report that antigen-specific cytolytic T-cell responses were amplified after immunization in 7 of 12 human leukocyte antigen-A2-expressing individuals, and that multiple immunizations seemed necessary to elicit PAP-specific interferon-γ-secreting immune responses detectable by enzyme-linked immunosorbent spot assay. Moreover, among individuals who experienced a ≥200% increase in prostate-specific antigen doubling time, long-term PAP-specific interferon-γ-secreting T-cell responses were detectable in 6 of 8, but in only 1 of 14 individuals without an observed change in prostate-specific antigen doubling time (P=0.001). Finally, we identified that immune responses elicited could be further amplified by subsequent booster immunizations. These results suggest that future trials using this DNA vaccine, and potentially other anti-tumor DNA vaccines, could investigate ongoing schedules of administration with periodic booster immunizations. Moreover, these results suggest that DNA vaccines targeting PAP could potentially be combined in heterologous immunization strategies with other vaccines to further augment PAP-specific T-cell immunity....

Matching Content Categories {📚}

  • Health & Fitness
  • Education
  • Law & Government

Content Management System {📝}

What CMS is doi.org built with?


Doi.org is based on MYBB.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌌 Gigantic Traffic: 2M - 5M visitors per month


Based on our best estimate, this website will receive around 4,026,036 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

The income method remains a mystery to us.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Doi.org has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

journal, dna, vaccines, responses, issue, vaccine, pap, tcell, immune, immunizations, access, subscribe, alerts, authors, abstract, clinical, prostate, cancer, antigen, antitumor, trials, booster, individuals, papspecific, log, register, logo, articles, issues, encoding, prostatic, acid, phosphatase, longterm, patients, recurrent, buy, tumor, elicit, investigated, conducted, subsequent, schedules, administration, future, amplified, immunization, interferonγsecreting, detectable, prostatespecific,

Topics {✒️}

immune responses elicited anti-tumor dna vaccines sustainable immune response author information journal earlier clinical trials recurrent prostate cancer future clinical trials full text access journal authors submit anti-tumor vaccines guiding optimal schedules investigate ongoing schedules artificial intelligence training subsequent booster immunizations dna vaccine periodic booster immunizations etoc alerts heterologous immunization strategies service request 800-638-3030 tumor antigen register subscribe individual subscribers log prostate cancer journal tables issue vaccine administration future trials pap elicit detectable website subscribe multiple immunizations journal center submit phase 1 trial immunologic efficacy questions aimed observed change results suggest email inbox rights reserved data mining previously conducted vaccines content individuals 14 individuals tumor investigated authors

Questions {❓}

  • Not a Subscriber?

Social Networks {👍}(1)

External Links {🔗}(58)

Analytics and Tracking {📊}

  • Comscore
  • Google Analytics
  • Google Tag Manager

Libraries {📚}

  • Bootstrap
  • FontAwesome
  • jQuery
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Cookielaw
  • Jsdelivr
  • Scite
  • Wolterskluwer

4.78s.